[ Price : $8.95]
FDA finalizes a guidance outlining how generic drug developers should evaluate the adhesion performance of transdermal and topical...[ Price : $8.95]
Novo Nordisk says its investigational anti-inflammatory drug ziltivekimab failed to reduce the risk of major adverse cardiovascula...[ Price : $8.95]
FDA issues a revised draft guidance updating its recommendations for how generic drug developers should evaluate the skin irritati...[ Price : $8.95]
FDA approves Novartis' Pluvicto (lutetium Lu 177 vipivotide tetraxetan) in combination with androgen receptor pathway inhibitor (A...[ Price : $8.95]
A new FDA draft guidance outlines how sponsors should develop and evaluate container closure systems and device components used wi...[ Price : $8.95]
A new Harvard Law School legal commentary argues that decades of policies designed to accelerate pharmaceutical innovation may hav...[ Price : $8.95]
FDA classifies a correction involving certain Argon Medical convenience kits as a Class I recall after identifying risks associate...[ Price : $8.95]
A BioProcess International column praises a new FDA final guidance for introducing some flexibilities into approval of cell and ge...